Download Trends in hospitalised injury, Australia: 1999–00 to 2012–13

TAG Mail 2 September 2015
TAG MEETINGS
Nil
TAG ACTIVITIES
**Life Saving Drugs Register
- A reminder for hospitals who have not completed the Life Saving Drugs Register survey (Antidotes) to enable
an update of information available on the NSWTAG website.
The link to the survey is: https://www.surveymonkey.com/r/GSC2JFD
- The Life Saving Drugs Register survey (Antivenoms) will be sent to hospital contacts today. It would be
appreciated if the survey could be completed by no later than 18 September 2015, to allow for the register to
be updated coinciding with the approaching snake bite and spider bite season.
The link to the survey is: https://www.surveymonkey.com/r/2015antivenom
TAG WEBSITE
Nil
REPORTS AND PUBLICATIONS – AUSTRALIA
**Australian Institute of Health and Welfare
Trends in hospitalised injury, Australia: 1999–00 to 2012–13
http://www.aihw.gov.au/publication-detail/?id=60129552564
**NSW Health
- Changes to prescribing and dispensing of Botulinum toxin and growth hormone
http://www0.health.nsw.gov.au/policies/ib/2015/IB2015_049.html
- Standards for paediatric intravenous fluids
http://www0.health.nsw.gov.au/policies/gl/2015/GL2015_008.html
**TGA
- List of Evaluated Registered Complimentary Medicines – Updated 27 August 2015
http://www.tga.gov.au/list-evaluated-registered-complementary-medicines
- Medical Devices and IVDs: Cancellations of certain devices within an entry
https://www.tga.gov.au/medical-devices-and-ivds-cancellations-certain-devices-within-entry
REPORTS AND PUBLICATIONS – INTERNATIONAL
**NICE Guidance List
- Bevacizumab for treating relapsed, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal
cancer (terminated appraisal)
http://www.nice.org.uk/guidance/ta353
- Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism
http://www.nice.org.uk/guidance/ta354
- Vedolizumab for treating moderately to severe active Crohn’s disease after prior therapy
http://www.nice.org.uk/guidance/ta352
**CADTH
- Antidepressants in Elderly Patients with Depression and Dementia: A Review of Clinical Effectiveness and
Guidelines
https://www.cadth.ca/sites/default/files/pdf/htis/aug-2015/RC0689%20%20Antidepressants%20in%20the%20Elderly%20Final.pdf
- Long-acting Opioids for Chronic Non-cancer Pain: A Review of the Clinical Efficacy and Safety
https://www.cadth.ca/sites/default/files/pdf/htis/aug-2015/RC0698%20Opioids%20Final.pdf
**EMA
- EPAR added: Phenylephrine/ketorolac eye drops (Omidria)
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003702/human_med_00
1888.jsp&mid=WC0b01ac058001d124
- EPAR added: Dinutuximab (Unituxin) for neuroblastoma
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002800/human_med_00
1891.jsp&mid=WC0b01ac058001d124
- EPAR added: Sebelipase alfa (Kanuma) for lysosomal acid lipase deficiency.
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004004/human_med_00
1896.jsp&mid=WC0b01ac058001d124
**FDA
- FDA approves evolocumab (Repatha) to treat certain patients with high cholesterol
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm460082.htm
- FDA extends use of eltrombopag (Promacta) in young children with rare blood disorder
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm459430.htm
-FDA approves new indication for eslicarbazepine as monotherapy for partial-onset seizures
http://www.biospace.com/News/sunovion-pharmaceuticals-inc-announces-fda/389559/source=MoreNews
**MHRA
-Early access to medicines scheme (EAMS) scientific opinion: sacubitril/valsartan
https://www.gov.uk/government/publications/early-access-to-medicines-scheme-eams-scientificopinion-sacubitrilvalsartan
**UKMi
-Prescribing Outlook New Medicines: horizon scanning for entries for new medicines, line extensions or
new formulations, including over 20 biosimilar formulations
http://www.ukmi.nhs.uk/filestore/ukmianp/2015PrescribingOutlook-NewMedicines-FINAL.pdf
MEDICATION SAFETY
**AHRQ
- Reducing errors through discharge medication reconciliation by pharmacy services.
http://www.psnet.ahrq.gov/resource.aspx?resourceID=29288
- Prevalence, nature, severity and risk factors for prescribing errors in hospital inpatients: prospective study in
20 UK hospitals
http://www.psnet.ahrq.gov/resource.aspx?resourceID=29168
**Health Canada
-Health Product InfoWatch, August 2015 includes information on paracetamol and liver injury, ferumoxytol,
clopidogrel and repaglinide interaction and a review article of rivaroxaban and liver injury
http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2015-08-eng.php#review
**FDA
- DPP-4 Inhibitors for Type 2 diabetes may cause severe joint pain
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm46023
8.htm
**ISMP
- ISMP comments on BD syringe potency issue
http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=117
- Draft Guidelines for the Safe Communication of Electronic Medication Information
http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=116
**TGA
- Medical Devices Safety Update Volume 3, Number 5, September 2015
http://www.tga.gov.au/publication-issue/medical-devices-safety-update-volume-3-number-5-september-2015
-Incidents have been reported of unsatisfactory spinal block with the use of Marcain Spinal 0.5% Heavy
(bupivacaine) by Astra Zeneca. At present there is no safety notice or drug withdrawal notice from either the
Therapeutics Goods Administration (TGA) or the sponsor Astra Zeneca. The TGA is aware of a number of
reports of the problem and is monitoring the situation. A notice has been posted on the College of
Anaesthetists website. Your assistance is requested to forward this information to all relevant staff and to
remind staff to notify the TGA if they experience unsatisfactory spinal block with this product at:
http://www.tga.gov.au/reporting-problems
PAPERS OF INTEREST
** American Journal of Medical Quality
-Unit-Based Interventions to Improve Teamwork and Patient Safety
http://ajm.sagepub.com/content/30/5?etoc
-Reporting of Health Care–Associated Infections
http://ajm.sagepub.com/content/30/5?etoc
-Predictors of 30-Day Hospital Readmission Following Ischemic and Hemorrhagic Stroke
http://ajm.sagepub.com/content/30/5?etoc
**Annals of Internal Medicine
-How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
http://annals.org/article.aspx?articleid=2362311
**Australian Health Review
-Should fee-for-service be for all guideline-advocated acute coronary syndrome (ACS) care? Observations from
the Snapshot ACS
http://www.publish.csiro.au/index.cfm?act=view_file&file_id=AH14153.pdf&utm_source=AHHA+Events+%26
+Publications+Newsletter&utm_campaign=299e94b76eAustralian+Health+Review+39%281%29&utm_medium=email&utm_term=0_a68a5446bc-299e94b76e245411241
-Healthcare resource use in patients of the Australian Transition Care Program Study
http://www.publish.csiro.au/index.cfm?act=view_file&file_id=AH14054.pdf&utm_source=AHHA+Events+%26
+Publications+Newsletter&utm_campaign=299e94b76eAustralian+Health+Review+39%281%29&utm_medium=email&utm_term=0_a68a5446bc-299e94b76e245411241
-Exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in
Australia and New Zealand
http://www.publish.csiro.au/index.cfm?act=view_file&file_id=AH14122.pdf&utm_source=AHHA+Events+%26
+Publications+Newsletter&utm_campaign=299e94b76eAustralian+Health+Review+39%281%29&utm_medium=email&utm_term=0_a68a5446bc-299e94b76e245411241
-Can clinical supervision sustain our workforce in the current healthcare landscape? Findings from a
Queensland study of allied health professionals
http://www.publish.csiro.au/index.cfm?act=view_file&file_id=AH14183.pdf&utm_source=AHHA+Events+%26
+Publications+Newsletter&utm_campaign=299e94b76eAustralian+Health+Review+39%281%29&utm_medium=email&utm_term=0_a68a5446bc-299e94b76e245411241
**BMJ Quality and Safety
-Development of the Quality Improvement Minimum Quality Criteria Set (QI-MQCS): a tool for critical appraisal
of quality improvement intervention publications
http://qualitysafety.bmj.com/content/early/2015/08/26/bmjqs-2014-003151.full.pdf+html
-How to build up the actionable knowledge base: the role of ‘best fit’ framework synthesis for studies of
improvement in healthcare
http://qualitysafety.bmj.com/content/early/2015/08/25/bmjqs-2014-003642.full.pdf+html
-Statistical process control and interrupted time series: a golden opportunity for impact evaluation in quality
improvement
http://qualitysafety.bmj.com/content/early/2015/08/27/bmjqs-2014-003756.extract
-A cluster-randomised quality improvement study to improve two inpatient stroke quality indicators
http://qualitysafety.bmj.com/content/early/2015/08/24/bmjqs-2015-004188.abstract
**Circulation: Cardiovascular Quality and Outcomes
-Comparison of the Abilities of Summary Measures of International Normalized Ratio Control to Predict
Clinically Relevant Bleeding
http://circoutcomes.ahajournals.org/content/early/2015/09/01/CIRCOUTCOMES.115.001768.abstract
**Diabetes care
-A Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin
in Patients With Type 2 Diabetes
http://care.diabetesjournals.org/content/early/2015/08/28/dc15-0811.abstract
**European Heart Journal
-Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of
patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv443
-Association between pre-operative statin use and major cardiovascular complications among patients
undergoing non-cardiac surgery: the VISION study
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv456
-2015 ESC Guidelines for the diagnosis and management of pericardial diseases
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv318
-2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without
persistent ST-segment elevation
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv320
-2015 ESC Guidelines for the management of infective endocarditis
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv319
-2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of
sudden cardiac death
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv316
-2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv317
** European Journal of Hospital Pharmacy
-A study of Foundation Year doctors’ prescribing in patients with kidney disease at a UK renal unit: a
comparison with other prescribers regarding the frequency and type of errors
http://ejhp.bmj.com/content/22/5/291.abstract
-The evolution of European Medicines Agency drug approval: the adaptive licensing
http://ejhp.bmj.com/content/early/2015/08/21/ejhpharm-2015-000740.full.pdf+html
-Pharmacist intervention in a psychiatric setting
http://ejhp.bmj.com/content/22/5/280.abstract
-Pharmacist intervention in pain management following heart surgery
http://ejhp.bmj.com/content/22/5/306.abstract
**Heart
-Acute myocardial infarction and influenza: a meta-analysis of case–control studies
http://heart.bmj.com/content/early/2015/08/26/heartjnl-2015-307691.abstract
Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis
http://heart.bmj.com/content/early/2015/08/28/heartjnl-2015-307930.abstract
**JAMA
- Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in
Patients With Heart Failure With and Without Atrial Fibrillation
http://jama.jamanetwork.com/article.aspx?articleid=2431702
**JAMA Internal Medicine
- Variability in Antibiotic Use Across Nursing Homes and the Risk of Antibiotic-Related Adverse Outcomes for
Individual Residents
http://archinte.jamanetwork.com/article.aspx?articleid=2337257
**JAMIA
- An algorithm to identify medication nonpersistence using electronic pharmacy databases
http://jamia.oxfordjournals.org/content/22/5/957
- Cross-vendor evaluation of key user-defined clinical decision support capabilities: a scenario-based
assessment of certified electronic health records with guidelines for future development
http://jamia.oxfordjournals.org/content/22/5/1081
- Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population
with diabetes
http://jamia.oxfordjournals.org/content/22/5/1094
- Report of the AMIA EHR-2020 Task Force on the status and future direction of EHRs
http://jamia.oxfordjournals.org/content/22/5/1102
**Journal of Clinical Oncology
-Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical
Practice Guideline Update
http://jco.ascopubs.org/content/early/2015/08/31/JCO.2015.62.1342.abstract
-Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F
http://jco.ascopubs.org/content/early/2015/08/31/JCO.2015.61.6474.abstract
**Journal of Pediatrics
Comparative Effectiveness of Dexamethasone versus Prednisone in Children Hospitalized with Asthma
http://www.jpeds.com/article/S0022-3476(15)00676-9/abstract
**Journal of The National Cancer Institute
-Impact of Fertility Concerns on Tamoxifen Initiation and Persistence
http://jnci.oxfordjournals.org/content/107/10/djv202.abstract
**NEJM
- Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
http://www.nejm.org/doi/full/10.1056/NEJMoa1507854?query=featured_home
- Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
http://www.nejm.org/doi/full/10.1056/NEJMoa1413687
- Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
http://www.nejm.org/doi/full/10.1056/NEJMoa1501035
**The Lancet
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or
traumatic brain injury: a double-blind randomised controlled trial
http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(15)00216-1/abstract
**The Lancet Oncology
-Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(15)00246-6/abstract
CONSULTATIONS
** ACSQHC
Consultation: Version 2 of the National Safety and Quality Health Service (NSQHS) Standards
http://www.safetyandquality.gov.au/our-work/accreditation-and-the-nsqhs-standards/current-consultations/
Closes 30 October 2015
**TGA
- Current consultation: Proposed Amendments to the Poisons Standard: bismuth oxychloride, naproxen,
pantoprazole, paracetamol/ibuprofen combination, piracetam. Due 3 rd September 2015.
https://www.tga.gov.au/consultation-invitation/consultation-proposed-amendments-poisons-standardmedicines
OTHER NEWS
Clinical Excellence Commission Medication Safety Project Officers - advertised internal to NSW Health with
closing date Friday 11 Sep 2015
Contact: Nina Muscillo, Manager, Medication Safety, CEC; Phone: 9269 5585
[email protected]
UPCOMING EVENTS (new additions in bold)
**CEC
NSW Antimicrobial Stewardship Forum, Sydney, 4th September
http://www.cec.health.nsw.gov.au/__data/assets/pdf_file/0010/279982/Flyer-and-Program-for-AMS-Forum2015.pdf
**ADMA 11th Annual National Conference: Count me in- Partnerships in chronic care
10th-11th September 2015, Brisbane Convention Centre, Queensland
http://www.adma.org.au/images/Conference_Flyer_2015.pdf
**ISMP
Medication Safety intensive, 17-18 September 2015, Bellevue WA, USA
https://www.ismp.org/orderforms/msi_registrations.asp
NSW Medicines Information Centre one-day Search Skills Workshop on Saturday September 19th. Cost: $
275. CPD: Non-accredited. 6 Group 1 CPD points, or 12 Group 2 CPD points (with assessment). Online
registration: https://svhs.org.au/home/research-education/education/courses-workshops-andconferences/allied-health/medicines-information-searching-skills-seminar
For more information contact the MIC on (02) 8382 3047 or [email protected]
** Monash University
Hot topics in healthy ageing: Research evidence, clinical skills and tools to manage an ageing population, 21
September 2015, Melbourne
http://www.med.monash.edu.au/sphpm/creps/seminars.html
**4th World Congress of Clinical Safety 2015, 28-30 September 2015, Vienna
http://www.iarmm.org/4WCCS/
**AHRQ
Agency for Healthcare Research and Quality (AHRQ) research conference, 4–6 October, 2015, Crystal City,
Virginia USA
Health care research and policy sessions on improving quality, safety, access and value in health care
http://www.ahrq.gov/news/events/conference/index.html
**ISQUA
Building Quality and Safety into the Healthcare System, 4-7 October 2015, Doha, Qatar.
http://www.isqua.org/conference/doha-2015/registration-2015?utm_source=Conference++Registration+Open+-+March+2015&utm_campaign=Conference+-+Reg+Open++March+2015&utm_medium=email
**National Hospital Procurement Conference, 29-30 October 2015, Sydney
http://www.informa.com.au/conferences/health-care-conference/national-hospital-procurementconference?utm_source=E-Pre&utm_medium=email&utm_campaign=P15a21
** APSA-ASCEPT 2015 Scientific Meeting, 28 November- 2 December 2015, Hobart
Abstract submission deadline: Friday 11 September 2015.
http://www.asceptasm.com/2015-annual-scientific-meeting/program-2015/
**SHPA
Medicines Management 2015, 3-6 December 2015, Melbourne Convention Centre.
http://mm2015shpa.com/
**APAMT (Asia Pacific Association of Medical Toxicology)
‘Remote, Resource and Retrieval Challenges in Toxicology’, 1-4 December 2015, Perth
http://www.apamt2015.com/
**EAHP
21st Congress of the EAHP (European Association of Hospital Pharmacists), 16-18 March 2016, Vienna, Austria.
‘Hospital pharmacists taking the lead – partnerships and technologies’
http://www.eahp.eu/congresses